Document Detail


Direct identification of a major autophosphorylation site on vascular endothelial growth factor receptor Flt-1 that mediates phosphatidylinositol 3'-kinase binding.
MedLine Citation:
PMID:  11513746     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Progress has been made in our understanding of the mechanism by which the binding of vascular endothelial growth factor (VEGF) to cognate receptors induces a range of biological responses, but it is far from complete. Identification of receptor autophosphorylation sites will allow us to determine how activated VEGF receptors are coupled to specific downstream signalling proteins. In the present study, we have expressed human VEGF receptors in insect cells using the baculovirus expression system, identified a major autophosphorylation site on the VEGF receptor fms-like tyrosine kinase-1 (Flt-1) by HPLC-electrospray ionization (ESI)-MS, and characterized in vitro interactions between Flt-1 and phosphatidylinositol 3'-kinase (PI3-kinase). Infection of High 5 insect cells with Flt-1 recombinant virus resulted in the expression of a 170 kDa glycoprotein, which bound VEGF with a K(d) of 2 x 10(-10) M in intact insect cells. The overexpressed recombinant Flt-1 receptors exhibited tyrosine kinase activity and were constitutively phosphorylated. Analysis of Flt-1 tryptic peptides by HPLC-ESI-MS with selective phosphate ion monitoring identified a hexapeptide (YVNAFK; where single-letter amino-acid code has been used) containing a phosphotyrosine (pTyr) residue at position 1213. Using synthetic phosphopeptides, this pTyr residue was found to be directly involved in the binding of PI3-kinase in vitro even though it did not fall within a consensus pYM/VXM PI3-kinase binding motif. These results suggest that phosphorylated Flt-1 associates with PI3-kinase at pTyr(1213) to mediate the activation of this pathway in VEGF signalling.
Authors:
Y Yu; J D Hulmes; M T Herley; R G Whitney; J W Crabb; J D Sato
Related Documents :
20950606 - Pharmacological profile of as1670542, a novel orally-active human thrombopoietin recept...
2541826 - Lateral diffusion of plasma membrane receptors labelled with either platelet-derived gr...
18484796 - Neovascular age-related macular degeneration: potential therapies.
2842336 - Rapid turnover of the platelet-derived growth factor receptor in sis-transformed cells ...
3771836 - 3h-nicotine and 125i-alpha-bungarotoxin-labeled nicotinic receptors in the interpeduncu...
6099156 - The binding of insulin-like growth factor ii to the erythroleukemia cell line k562.
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  The Biochemical journal     Volume:  358     ISSN:  0264-6021     ISO Abbreviation:  Biochem. J.     Publication Date:  2001 Sep 
Date Detail:
Created Date:  2001-08-21     Completed Date:  2001-10-04     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  2984726R     Medline TA:  Biochem J     Country:  England    
Other Details:
Languages:  eng     Pagination:  465-72     Citation Subset:  IM    
Affiliation:
Surgical Research Laboratory, Children's Hospital, Boston, MA 02115, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
1-Phosphatidylinositol 3-Kinase / metabolism*
Animals
Binding Sites
Cells, Cultured
Cloning, Molecular
Endothelial Growth Factors / metabolism
Endothelium, Vascular / metabolism
Glycosylation
Humans
Lymphokines / metabolism
Mass Spectrometry
Phosphorylation
Phosphotyrosine / metabolism
Protein Binding
Proto-Oncogene Proteins / chemistry*,  genetics,  metabolism*
Receptor Protein-Tyrosine Kinases / chemistry*,  genetics,  metabolism*
Recombinant Proteins / chemistry,  metabolism
Spodoptera / genetics
Transfection
Vascular Endothelial Growth Factor A
Vascular Endothelial Growth Factor Receptor-1
Vascular Endothelial Growth Factors
Grant Support
ID/Acronym/Agency:
EY06603/EY/NEI NIH HHS; P40-RR15452/RR/NCRR NIH HHS
Chemical
Reg. No./Substance:
0/Endothelial Growth Factors; 0/Lymphokines; 0/Proto-Oncogene Proteins; 0/Recombinant Proteins; 0/Vascular Endothelial Growth Factor A; 0/Vascular Endothelial Growth Factors; 21820-51-9/Phosphotyrosine; EC 2.7.1.137/1-Phosphatidylinositol 3-Kinase; EC 2.7.10.1/Receptor Protein-Tyrosine Kinases; EC 2.7.10.1/Vascular Endothelial Growth Factor Receptor-1
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Biochemical characterization of the beta-1,4-glucuronosyltransferase GelK in the gellan gum-producin...
Next Document:  Regulation of SulA cleavage by Lon protease by the C-terminal amino acid of SulA, histidine.